Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism
about
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionResearch gaps in defining the biological link between HIV risk and hormonal contraceptionHuman papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitorQuantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwashThe mouth: a gateway or a trap for HIV?Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safetyMucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression.The transcriptome of Trichuris suis--first molecular insights into a parasite with curative properties for key immune diseases of humans.Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicidesHSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression.HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolatesFemale genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice.Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinomaParacrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cellsSystemic and mucosal differences in HIV burden, immune, and therapeutic responsesActivation and evasion of innate antiviral immunity by herpes simplex virusEvasion of early antiviral responses by herpes simplex viruses.Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidalCoinfecting viruses as determinants of HIV disease.Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergyHerpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.Chronic bystander infections and immunity to unrelated antigens.Changes in the soluble mucosal immune environment during genital herpes outbreaks.Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.HIV transmission: time for translational studies to bridge the gap.Novel approaches in fighting herpes simplex virus infectionsInnate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine.Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation.Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.Herpes simplex activation prolongs recovery from severe burn injury and increases bacterial infection risk.Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention.Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.Alarm Anti-protease Trappin-2 Negatively Correlates With Proinflammatory Cytokines in Patients With Periodontitis.RNAseq reveals hypervirulence-specific host responses to M. tuberculosis infection
P2860
Q21134079-C5125697-0C5A-49B5-A6C9-F121DDF3F72FQ27002559-843D1922-3182-4E94-83BD-491CE438C47DQ28286766-2A1BBCDE-26A1-48EA-856B-A09ECCCF5157Q28300527-814FD272-A1DD-4DCE-95BA-FDA5622330BAQ33874252-22A53D40-F180-40E3-8AE3-EE7C970F02F1Q33880947-A8E212BB-8A43-486B-9553-3F5DE03279D4Q33911933-5E0B356B-619A-4007-AFF1-55B4ACC0BB6CQ34009430-320F8393-B859-4AD0-8B20-385382B848F3Q34064986-BF916C1D-E463-4645-89A6-9F8CC2A68EE8Q34333815-11BE63AB-28A2-4408-8268-310AC807B35FQ34537743-7A186676-489F-4CA1-810E-DCF1AD955962Q34680240-714A4DD4-6B13-45D1-86EB-8BC670466600Q35014657-2C3B746A-C4EB-4AC9-BFDC-0EB98A6BBDDCQ35071264-02D277CB-4236-4B2A-85D5-98369D0596A6Q35154168-039F3C68-BA11-4D49-AF65-E0ABFD484B8AQ35190200-CDC8FB60-7922-4FC9-AF2B-343796BD1022Q35259878-DA18A8F0-C8FF-411F-8BD6-E096766212DEQ35414669-7B60CD7C-09DF-4501-84CE-7DAD63C56CB8Q36092095-EB4BBF70-0FF0-467C-9426-ACFF9328221BQ36189825-A42DCA8B-4B97-4026-81D6-2D8E35C7E375Q36559887-792FBE78-4DE1-4A57-83AD-2991DBFD9872Q36720700-C08B7501-C36A-4A24-8009-030C0AF6D1E4Q36743201-C0FD1413-B04C-477D-BAA9-A35C95DD0B83Q36937188-9FE8B1BA-68DD-4855-AA3F-BEF16F609EABQ36978882-1B609586-F38E-4EBE-8DB0-3152998C96F8Q37156924-8D599D6C-D330-4CC0-960B-2E06E6BE608BQ37316071-A66915DB-F8DF-4490-A34F-0B05BDDB08C0Q37334286-D7D2AD85-0366-4413-AEFF-289FABC7DDF1Q37520175-D28187F4-3137-45E4-8218-7DC1B28BA0B4Q37611796-B1D930AC-4B57-4841-B1C9-FBB271959299Q37693958-3C077737-7659-43AC-91D0-7C46A128541CQ37731798-684634BD-D9A2-431F-A1BC-56F6FE8B03D0Q37955615-D10D9F0F-FF43-4367-B05E-A3F2ABDAB4A7Q38049148-F8C082DA-8740-4756-B0C4-2FC544683F31Q38206217-FB9A0CFA-2339-49F6-BFDA-9F987915DAB0Q38241377-D3D120BE-46CB-45DD-9AA6-6FECFE98A520Q38801593-B4BE4FAE-4EE9-4706-A29A-BDFE7FEBE51CQ39547383-267ECD63-6C65-4ACA-8F6E-D7358A02FDADQ40106689-60AEFDB1-D55C-4427-9429-7B7828E885F7Q40496836-667713E2-C060-43A7-B02F-5CE30169C93A
P2860
Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Herpes simplex virus downregul ...... novel immune evasion mechanism
@en
type
label
Herpes simplex virus downregul ...... novel immune evasion mechanism
@en
prefLabel
Herpes simplex virus downregul ...... novel immune evasion mechanism
@en
P2093
P2860
P356
P1433
P1476
Herpes simplex virus downregul ...... novel immune evasion mechanism
@en
P2093
Betsy C Herold
Ehsan Hazrati
Esra Fakioglu
John A Blaho
Natalia Cheshenko
Sarah S Wilson
P2860
P304
P356
10.1128/JVI.00603-08
P407
P577
2008-07-30T00:00:00Z